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ABSTRACT
There are numerous forkhead transcription factors in
mammalian cells but we know little about the molec-
ular functions of the majority of these. FOXK2 is
a ubiquitously expressed family member suggest-
ing an important function across multiple cell types.
Here, we show that FOXK2 binds to the SIN3A and
PR-DUB complexes. The PR-DUB complex contains
the important tumour suppressor protein, the deu-
biquitinase BAP1. FOXK2 recruits BAP1 to DNA,
promotes local histone deubiquitination and causes
changes in target gene activity. Our results therefore
provide an important link between BAP1 and the tran-
scription factor FOXK2 and demonstrate how BAP1
can be recruited to specific regulatory loci.
INTRODUCTION
The forkhead transcription factor family contains over 40
members and all of these contain a forkhead winged helix-
turn-helix DNA binding domain (1,2). This domain is re-
sponsible for sequence-specific DNA binding, generally to
sites resembling the RYMAAYA (R = A or G; Y = C or
T; M = A or C) core motif ((3,4); reviewed in (1)). Many
of these proteins are expressed in a restricted or cell type-
specific manner but a group of these are ubiquitously ex-
pressed across many cell types, including the related pro-
teins FOXK1 and FOXK2. In addition to the forkhead
DNA binding domain, FOXK1 and FOXK2 also contain
a FHA domain in their N-terminal regions. FOXK1 has
been the best studied of these proteins and the mouse ho-
mologue of FOXK1, MNF, has been shown to regulate
the proliferation of myogenic stem cells (5,6). Molecularly,
FOXK1/MNF acts in a repressive manner and can do so
through recruitment of SIN3-containing co-repressor com-
plexes (7,8). Human FOXK1 has been less studied but can
associate with serum response factor (SRF) and modulate
its transcriptional activity (9). Comparatively less is known
about the function of FOXK2. FOXK2 was initially iden-
tified as a regulator of IL-2 transcription (10). Molecularly,
few binding partners have been identified but it can bind to
transforming proteins adenoviral E1A and papillomavirus
E6 (11) and to AP1 family members (12). Little is known
about upstream regulatory pathways but a link to the cell
cycle is suggested by the observation that FOXK2 is phos-
phorylated by cyclin dependent kinase (CDK)–cyclin com-
plexes (13). In addition to potential transcriptional roles, an
alternative function in DNA repair is suggested by the ob-
servation that FOXK2 can bind to DNA containing G/T-
mismatches (14).
Our genome-wide ChIP-seq studies showed that FOXK2
binds to thousands of regions spread throughout the
genome where it can promote AP1 binding at a subset of
sites (12). One possible role for FOXK2 in this context
would be to modify chromatin structure but how FOXK2
might achieve this is unclear. Here, we have searched for co-
regulatory partners for FOXK2 and identified the SIN3 and
polycomb repressive deubiquitinase (PR-DUB) complexes.
We focussed on verifying functional interactions with the
PR-DUB complex as this contains the important tumour
suppressor protein BAP1 (reviewed in (15)) and demon-
strated that FOXK2 acts as a sequence-specific binding
transcription factor to recruit BAP1 to chromatin and pro-
mote local histone deubiquitination.
MATERIALS AND METHODS
Plasmid constructs
The following plasmids were used in mammalian cell trans-
fections. pAS1178 (pCDNA3–GAL4–FOXK2–FHA),
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has been described previously. The following plasmids
were constructed to express N-terminally Flag-tagged
human BAP1: pAS1443 [pCDNA3–Flag–BAP1(1–729)],
pAS1447 [pCDNA3–Flag–BAP1(1–598)] and pAS1448
[pCDNA3–Flag–BAP1(241–729)], which were generated
by ligating BamHI/NotI double digested PCR products
generated with the oligonucleotide pairs ADS3817/3819,
ADS3817/3821 and ADS3820/3819, respectively, on the
template pOTB7–BAP1 (GenomeCube, IMAGE ID:
3543914), into the same sites from the vector pAS3010.
pAS3010 contains FOXO3 cloned in frame with an N-
terminal Flag tag (using a BamHI site) into pCDNA3
(kindly provided by Alan Whitmarsh).
The plasmids used in glutathione S-transferase
(GST) pulldown experiments were pAS2194 [encoding
GST–FOXK2(1–218) and pAS2195 (encoding GST–
FOXK2(189–660))] (13). The FOXK2 FHA domain mu-
tant GST–FOXK2(1–218)(R58A) (pAS1450), was made
by Quikchange mutagenesis using the primer–template
combination ADS3825/ADS3826–pAS2194.
Tissue culture, cell transfection and RNA interference
U2OS and HEK293T cells were grown in Dulbecco’s mod-
ified Eagle’s medium (DMEM) supplemented with 10%
foetal bovine serum. U2OS cells stably expressing FOXK2–
HF (U2OS–FOXK2–HF) (12) were grown in DMEM
supplemented with 1.5 g/ml puromycin and 10% foetal
bovine serum.
To construct U2OS cell lines stably expressing shFOXK2
or a matched control cell line, non-silencing pGIPZ lentivi-
ral shRNAmir control vector (RHS4346) and human
GIPZ FOXK2 shRNA (RHS4430-101517573, clone ID:
V3LHS 308724) were transfected into U2OS cells using
TurboFect Transfection Reagent (Thermo Scientific). Cells
were then subjected to selective pressure using 5 g/ml
puromycin. Single cells were then expanded into colonies
to generate individual clonal cell lines. FOXK2 protein level
was barely detectable by immunoblotting in clonal lines 5-1
and F5-1 that were subsequently used in this study.
For plasmids transfection, 3 × 106 HEK293T cells were
transfectedwith 8g of plasmid. Transfections were carried
out using Polyfect (Qiagen) transfection reagent. After 24 h,
cells were harvested and used for co-immunoprecipitation
assays.
siRNAs for FOXK2 and BAP1 were ON-TARGETplus
SMART pools from Dharmacon (L-008354-00-0005 and
L-005791-00-0005), control non-targeting siRNAs (Dhar-
macon, D-001810-01-50) were used throughout. To carry
out RNA interference (RNAi), cells were transfected with
50 nM siRNA using Lipofectamine R© RNAiMAX (Invit-
rogen) according to the manufacturer’s instructions. Forty-
eight hours after transfection, the cells were harvested for
further analyses.
Western blot analysis, co-immunoprecipitation and GST
pulldown assays
Western blotting was carried out with the primary anti-
bodies; FOXK2 (A301-729A), HCFC1 (A301-400A) and
ASXL2 (A302-037A) from Bethyl Laboratories; BAP1 (C-
4, SC-28383), mSIN3A (K20, sc-994), Gal4 (sc-577) and
ERK2 (sc-154) from Santa Cruz Biotechnology; Flag M2
(F3165) from Sigma; HDAC1(ab1767) from Abcam. West-
ern blots derived from whole cell lysates or immunoprecipi-
tated proteins were visualized after incubationwith primary
antibodies using Infrared IRDye-labelled secondary anti-
bodies and the signal was collected with a Li-Cor Odyssey
infrared imager.
Co-immunoprecipitation was performed as previously
described (12), antibodies used for immunoprecipitation:
FOXK2 (anti-ILF1 antibody, ab5298, Abcam); antibodies
for Flag, BAP1 and Gal4 as described above; for each im-
munoprecipitation, normal IgG was used as negative con-
trol: rabbit (12–370), mouse (12–371) IgG from Millipore
and normal goat IgG (sc-2028) from Santa Cruz Biotech-
nology. For interrogating phosphorylation-dependent in-
teractions, co-immunoprecipitated proteins were treated
with 400 units of -phosphatase (NEB P0753S) for 30 min
at 30◦C followed by four further washes in immunoprecipi-
tation buffer prior to loading on a gel.
GST pulldown analysis was performed essentially as de-
scribed previously (16), with purified bacterially expressed
recombinant GST–FOXK2 derivatives and either total cell
extracts from U2OS cells or in vitro translated 35S-labelled
BAP1 protein synthesized using theTNTT7Quick-coupled
transcription/translation system (Promega). Where indi-
cated, ethidium bromide (200g/ml) was added to theGST
pulldown reactions.
Proteomic analysis
Rapid immunoprecipitation mass spectrometry of endoge-
nous proteins (RIME) was performed as described previ-
ously (17). U2OS–FOXK2–HF cells and the control ‘empty
vector’ U2OS–HF cells were grown in complete DMEM in
the presence of 1.5 g/ml puromycin. Anti-Flag M2 anti-
body (F3165, Sigma) was used for immunoprecipitation of
cross-linked FOXK2.
The interaction networks of FOXK2 associated proteins
identified using RIME were analysed using STRING (18),
with parameters set for Active Prediction Methods as ex-
periments, textmining and databases.
Immunofluorescence analysis and proximity ligation assay
Immunofluorescence experiments were performed as de-
scribed previously (13). DNA was stained with 4’,6-
diamidino-2-phenylindole (DAPI) using mounting medium
of ProLong Gold Antifade Reagent (Invitrogen). The
Duolink In SituRed StarterKitMouse/Rabbit (Sigma)was
used for proximity ligation assay (PLA) experiments.U2O,S
U2OS–FOXK2–HF or shFOXK2 clonal line 5-1 cells were
seeded onto coverslips at 5 × 104 cells per well in a 12-
well plate. The cells were fixed with 4% paraformaldehyde–
phosphate buffered saline (PBS) at room temperature for
30 min and permeabilized using 0.2% Triton-X100–PBS
for 6 min. After permeabilization, the cells were incubated
in the blocking buffer (5% bovine serum albumin (BSA)–
PBS, freshly prepared) for 30 min at room temperature
(RT). Cells were then incubated with the primary antibod-
ies diluted in the antibody diluents for 1 h at RT. For the
rest of the assay, the manufacturer’s instructions were fol-
lowed. The coverslips were mounted using DUOLINK in
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situ mounting medium with DAPI. Images were collected
on an Olympus BX51 upright microscope using a ×63 oil
immersion objective and captured using a Coolsnap ES
camera (Photometrics) throughMetaVue Software (Molec-
ular Devices). Images were then processed and analysed us-
ing ImageJ. To quantify the PLA signals, 5–10 image sec-
tions were analysed for the ratio of signals per nuclei. The
negative control level was set to 1.
RT-PCR and chromatin immunoprecipitation (ChIP) assays
Total RNA was isolated using a RNeasy kit (Qiagen) and
transcripts detected in a one-step RT-PCR reaction using
Quantitect SYBR green reagent (Qiagen). The primer-pairs
used for RT-PCR experiments are listed in Supplementary
Table S1A.
ChIP assays using control IgG (Millipore) or antibodies
specific to BAP1, FOXK2, HCFC1, ASXL2, Flag, H2A
(ab18255, Abcam) and ubiquityl-histone H2A (Lys119)
(H2Aub, D27C4, 8240S, from Cell Signaling Technology),
were performed essentially as described previously (12), us-
ing 1 × 106 to 5 × 106 U2OS cells for a standard ChIP.
Bound regions were detected by quantitative PCR (qPCR)
(using primers listed in Supplementary Table S1B), from at
least two independent experiments, using Quantitect SYBR
green PCR reagent (Qiagen). Results were analysed with
Rotorgene Q software (Qiagen) relative to input using the
standard curve method. ChIP-seq analysis for Flag-tagged
FOXK2 and Flag-tagged BAP1 from U2OS–FOXK2–HF
andU2OS–BAP1–HFcells was performed essentially as de-
scribed previously (12).
Statistical analysis for real-time PCR results was per-
formed using the Student’s t-test. The error bars in all
graphs represent standard deviation.
Bioinformatics analysis
For microarray analysis, we first examined our previously
published datasets following treatment of U2OS cells with
either siFOXK2 or siGAPDH as a control (Array Express
E-MEXP-3106) (12). Each experiment was performed us-
ing the Affymetrix hgu133plus2.0 microarray platform, and
repeated in triplicate. Raw intensity CEL files for these
six datasets were normalized, and converted to estimates
of probe set expression level, using the robust multiar-
ray averaging (RMA) algorithm from the affy (19) pack-
age in R. Differential expression between siFOXK2 and
siGAPDH treated cells was then estimated using unpaired
t-tests within the limma package in R (20). Probe set iden-
tifiers were converted to protein-coding gene symbols (En-
sembl v.73 gene symbols, and HGNC identifiers) using the
most recent mappings provided by Affymetrix. In all con-
texts, we used the Ensembl v.73 protein-coding gene collec-
tion, obtained through the BioMart portal (v0.7), retaining
both known and novel protein-coding transcripts (21). In
total, 18 409 Ensembl gene identifiers matched at least one
probe set on the hgu133plus2.0 platform.We also examined
externally published datasets on the same microarray plat-
form (hgu133plus2.0), following treatment of U2OS cells
with either shBAP1 or a control shRNA (GEO:GSE23035)
(22). Two different shRNAs specific to BAP1 were used,
and all experiments repeated in triplicate, giving nine ar-
rays in total. Raw intensity CEL files were normalized as
before using RMA, and differential expression between the
six shBAP1 arrays and three shControl arrays estimated us-
ing the limma package in R.
For ChIP-seq analysis, we used our Illumina ChIP-seq
read libraries for FOXK2-bound compared to input DNA
in U2OS cells (ArrayExpress: E-MTAB-2204), together
with externally published ChIP-seq read libraries for DNA
bound byHCFC1, compared to input, in HeLa cells (GEO:
GSE31417) (23). We did not reanalyse previously published
SOLiDChIP-seq read libraries (12) due tomore recent find-
ings that this technology suffers from bias against CpG-
enriched regions, including many active gene promoter re-
gions (our unpublished data). Read libraries were mapped
to the human genome (hg19) using Bowtie v1.0 with strin-
gent settings (v = 1, m = 0) (24). In all cases, peak-calling
was carried out usingHOMER (v4.2), searching for narrow
binding regions (style = factor), and with default settings
(Poisson threshold p= 10−3) (25). Peak locations were com-
pared to one another and to protein-coding gene transcrip-
tion start sites (TSSs) using in housemethodswritten in Java
(code available upon request). The density of FOXK2 and
HCFC1 tags within 5 kb regions centred on FOXK2 peak
centres was visualized using Seqminer v1.3.3 (26).
Statistical analysis
To annotate genes as up-regulated, unchanged, or down-
regulated, upon siFOXK2 or siBAP1 treatment, we im-
posed a range of fold change (fc) cut-offs (1.2, 1.3, 1.4 and
1.5) compared to control siRNA treatment (pnominal < 0.05).
Rarely, a gene with multiple probe sets passed thresholds
for both up- and down-regulation, and in such cases the
genes were omitted from further statistical analysis. At each
fold change cut-off, we then measured the significance of
overlaps between gene lists up- or down-regulated upon ei-
ther siFOXK2or shBAP1 using the hypergeometric test.We
found results were independent of the fold change param-
eter (data not shown), so we report the results for the rel-
atively less stringent fc = 1.2 (up-regulation) or fc < 1/1.2
(down-regulation).
RESULTS
FOXK2 binds to the BAP1-containing PR-DUB complex
To further our understanding of FOXK2 function, we used
RIME (17) to identify novel FOXK2 binding partners. This
technique is designed to maximize the chances of isolating
factors that are associated with chromatin-bound FOXK2,
by using formaldehyde-mediated cross-linking prior to im-
munoprecipitating FOXK2 (Figure 1A). Immunoprecipta-
tions (IPs) were performed using anti-Flag antibody using
extracts from cross-linked U2OS–FOXK2–HF cells which
harbour Flag-tagged FOXK2 expressed at endogenous lev-
els (12), and the resulting immunoprecipitates were anal-
ysed by mass spectrometry. This resulted in the identifica-
tion of FOXK2 as expected (32 peptides giving 65% cov-
erage) but also 119 proteins that were not also identified
in control IPs from U2OS–HF cells. Amongst these pro-
teins were proteins belonging to the SIN3A core complex
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Figure 1. Identification of FOXK2 binding proteins by RIME. (A) Schematic illustration of the RIME protocol used to identify FOXK2 associated factors
in the context of chromatin association. (B) Summary of FOXK2 interaction proteins belong to the SIN3A core complex and the PR-DUB complex.
HCFC1 is shown in brackets as it is unclear whether this is part of the core PR-DUB complex. (C) Visualization using STRING of a sub-network of
interactions between FOXK2 binding proteins. (D) Validation of FOXK2 interaction with endogenous components of SIN3A and PR-DUB core complex
proteins by co-immunoprecipitation (IP) experiments using anti-Flag (FOXK2) antibody in U2OS–FOXK2–HF cells. Precipitated proteins were detected
by immunoblotting (IB) using the antibodies as indicated. Arrows represent the bands corresponding to each of the full-length proteins. Note that the
ASXL2 blot is from a different IP experiment. (E) PLA analysis of interaction between Flag-tagged FOXK2 and endogenous HCFC1 in U2OS–FOXK2–
HF (top and bottom left panels) or U2OS (bottom right) cells. The combinations of antibodies used are shown above and below each panel (IgG represents
a non-specific antibody). DNA is stained using DAPI (blue) and the PLA signal is red. Quantitative analysis of PLA signals in the nucleus is shown below.
The level of signals/nuclei in the control PLA sample (Flag and non-specific IgG antibodies) was set as 1.
and the PR-DUB complex (Figure 1B). The association
with a SIN3-like complex was expected as the closely re-
lated protein FOXK1 has previously been shown to bind
to SIN3A and SIN3B (7,8) whereas binding of FOXK2 to
the PR-DUB complex was novel. Interestingly, several of
the proteins in these two complexes were also identified in
reciprocal IPs for BAP1 interacting proteins (Figure 1B)
(27,28). Moreover, analysis of the FOXK2 interactome us-
ing STRING (18) revealed an interconnected sub-network
containing both the SIN3A and PR-DUB complexes, with
binding to HCFC1 providing the links between the two
complexes (Figure 1C). Interactions between Flag-tagged
FOXK2 and endogenous HDAC1 and SIN3A components
of the SIN3A core complex were verified by co-IP (Fig-
ure 1D). Similarly, we were able to verify FOXK2 interac-
tions with the PR-DUB complex components BAP1 and
ASXL1 but were only able to detect weaker co-associations
withHCFC1 in co-IP experiments (Figure 1D). To establish
whether HCFC1 interacted with FOXK2 in vivo, we instead
used the in situ PLA which can detect protein–protein in-
teractions in cells with high specificity and sensitivity. Incu-
bation of cells stably expressing Flag-tagged FOXK2 with
either the Flag or HCFC1 antibody alone resulted in only
background signals. However, co-incubation with both an-
tibodies together gave a strong PLA signal but this was only
apparent when the cells contained Flag-tagged FOXK2 and
was not observed in parental U2OS cells. These results are
indicative of a close association of HCFC1 and FOXK2
(Figure 1E).
BAP1 has recently been implicated as an important tu-
mour suppressor protein in a number of different tumour
types (reviewed in (29)) and found to be one of seven genes
whose mutation is the most indicative of poor prognos-
tic outcome (30). We therefore focussed on the PR-DUB
complex and on BAP1 in particular for further investiga-
tion. First, we demonstrated that endogenous FOXK2 and
BAP1 interact in reciprocal co-IP experiments (Figure 2A
and B). Both proteins are found in the nuclear pellet frac-
tion (Supplementary Figure S1) and immunofluorescence
microscopy showed that their expression patterns within
the nucleus show substantial overlap (Figure 2C). To gain
a higher resolution view of their co-localization, we again
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Figure 2. Interactions between endogenous FOXK2 and BAP1. Re-
ciprocal co-immunoprecipitation experiments using either FOXK2 (A)
or BAP1 (B) antibodies for immunoprecipitation (IP) from U2OS cells.
Co-precipitated endogenous BAP1 and FOXK2 were detected by im-
munoblotting (IB). Arrows represent the bands corresponding to each of
the full-length proteins. (C) Immunofluorescence detection of endogenous
FOXK2 (green) and BAP1 (red) and their co-localization in the nucleus
[indicated by DAPI staining of DNA (blue)]. (D) Imaging and quantifica-
tion of PLA signals generated by the indicated combinations of antibod-
ies (IgG represents a non-specific antibody). DNA is stained using DAPI
(blue) and the PLA signal is red. Quantitative analysis of PLA signals in
the nucleus is shown on the right. The level of signals/nuclei in the control
PLA sample (BAP1 and non-specific IgG antibodies) was set as 1.
turned to the PLA assay to examine whether FOXK2 and
BAP1 are closely juxtaposed in vivo. Incubation of cells
with either the FOXK2 or BAP1 antibody alone resulted
in only background signals. However, co-incubation with
both antibodies together gave a strong PLA signal (Figure
2D, left panels). Importantly, this signal was equivalent to
that seen between BAP1 and either the PR-DUB compo-
nent ASXL2 or the closely associated protein HCFC1 (Fig-
ure 2D, right panels). Importantly the PLA signals between
FOXK2 and BAP1 were lost in a stable cell line where en-
dogenous FOXK2 is depleted by expression of an shRNA
against FOXK2 (Figure 2D, bottom right panel). Together
these results firmly establish BAP1 from the PR-DUB com-
plex as an interaction partner for FOXK2.
Mapping the FOXK2–BAP1 interaction domains
To provide insights into complex formation between
FOXK2 and BAP1, we first mapped the region of FOXK2
responsible for binding to BAP1. First we carried out in
vitro GST pulldown assays with GST fusions to the N-
and C-terminal parts of FOXK2 (Figure 3A). Strong in-
teractions with BAP1 were seen with FOXK2(1–218) con-
taining the N-terminal region whereas background bind-
ing was seen to the C-terminal FOXK2(189–660) construct
(Figure 3B, lanes 4 and 5). Binding of BAP1 to the N-
terminal region of FOXK2 in vivo was confirmed by co-
IP of a GAL–FOXK2(1–218) fusion protein (Figure 3C).
To rule out the possibility that the interactions we de-
tect are indirect and mediated by contaminating DNA, we
performed a GST pulldown assay with GST–FOXK2(1–
218) and total U2OS cell lysates and investigated BAP1
interactions in the presence and absence of ethidium bro-
mide. The inclusion of ethidium bromide had no effect
on FOXK2–BAP1 interactions (Figure 3D), demonstrating
that the interactions are not DNA-mediated. FOXK2(1–
218) contains the FHA domain which has been shown to
be a phosphopeptide binding domain in other proteins (re-
viewed in (31)). Further truncations of the regions located
N- and C-terminally to the FHA domain created proteins
FOXK2(52–218) and FOXK2(1–128) which were still ca-
pable of binding FOXK2 in vitro (Supplementary Figure
S2) implicating the FHA domain as important for BAP1
binding. However, the FHA domain alone was insufficient
for BAP1 binding, possibly due to incorrect folding in this
truncated construct. Given the fact that the FHA domain
is important for BAP1 binding, we tested an R58A mu-
tant version of FOXK2 which is predicted to ablate its
phosphopeptide binding activity (31). Reduced binding of
BAP1 was observed with FOXK2(R58A) (Figure 3E, top
panel). Moreover, binding to both HCFC1 and SIN3A was
also reduced. This suggested a role for phosphorylation-
dependent interactions between FOXK2 and its interaction
partners. To test whether this was indeed the case, we re-
peated a co-immunoprecipitation experiment, but treated
the co-precipitates with  phosphatase to remove any phos-
phate groups. Both BAP1 and FOXK2 showed mobility
changes, indicative of dephosphorylation, but there was no
effect on FOXK2–BAP1 interactions (Figure 3F). Further-
more, treatment of cells with the CDK inhibitor alster-
paullone had little effect on FOXK2–BAP1 interactions
(Supplementary Figure S2C). It therefore appears likely
that the R58A mutation does more than affect phospho-
dependent interactions but underscores the importance of
this domain in mediating interactions between FOXK2 and
BAP1.
Next, we turned to BAP1 and deleted either the N-
terminal ubiquitin carboxyl-terminal hydrolase (UCH) do-
main or the C-terminal domain (CTD) which contains the
UCH37-like domain (ULD) and nuclear localization signal
(NLS) (Figure 3G). Surprisingly, deletion of either domain
reduced interactions between Gal–FOXK2(1–218) in co-IP
experiments, although the lower expression of BAP1(241–
729) likely contributed to the lower levels of interaction
observed (Figure 3H, first and third panels). Similarly, in-
teractions between BAP1 and HCFC1 were reduced upon
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Figure 3. Mapping the FOXK2–BAP1 interaction domains. (A) Schematic representation of full-length FOXK2 and the GST fusions to the C-terminal
(amino acids 1–218) and N-terminal (amino acids 189–660) regions of FOXK2. The positions of the forkhead associated (FHA) and forkhead domains
(FOX) are shaded in grey. (B) GST pulldown assays using bacterially expressed GST-tagged FOXK2(1–218) and FOXK2(189–660) and in vitro translated
BAP1. Arrows mark the positions of full-length GST–FOXK2 fusion proteins. A total of 10% input is shown. (C) Co-immunoprecipitation experiments
to analyse interactions between FOXK2(1–218) and BAP1. HEK293T cells were transfected with the indicated plasmids encoding FOXK2(1–218) fused
with the Gal4 DNA binding domain and Flag-tagged BAP1, followed by immunoprecipitation (IP) with anti-Flag antibody and immunoblotting (IB)
with either an anti-Flag or an anti-Gal4 antibody. ERK2 is a loading control. The asterisk marks a non-specific signal. (D and E) GST pulldown assay
using either GST, or wild-type (WT) or FHA mutant (R58A) versions of the GST–FOXK2(1–218) fusion protein and total cell extracts from U2OS cells.
Interacting BAP1, HCFC1, SIN3A and input GST fusion proteins were revealed by IB. Arrows mark the positions of full-length GST–FOXK2 fusion
proteins. A total of 3% cell lysate input is shown. Ethidiumbromidewas added to theGSTpulldown reactions where indicated. (F) Co-immunoprecipitation
experiments using FOXK2 antibodies for IP from U2OS cells. Co-precipitated endogenous BAP1 was detected by IB. Where indicated, the final co-IP was
treated with  phosphatase. (G) Schematic representation of full-length BAP1 and the indicated N- and C-terminal truncation mutants. The locations of
the ubiquitin carboxyl-terminal hydrolase (UCH) domain and the C-terminal domain (CTD) are shown. (H) Co-immunoprecipitation analysis of FOXK2
interactions with BAP1 deletion mutants. HEK293T cells were transfected with the indicated plasmids encoding FOXK2(1–218) fused to the Gal4 DNA
binding domain and Flag-tagged full-length or truncatedmutants of BAP1, followed by IP with anti-Flag antibody and IBwith the anti-Gal4, anti-HCFC1
and anti-Flag antibodies. The asterisk marks a non-specific signal.
truncation of either its N- or C-terminal domains (Fig-
ure 3H, second panel). As loss of the UCH domain in
the BAP1(241–729) construct reduces FOXK2 binding we
tested whether the deubiquitination activity of BAP1 is re-
quired for FOXK2 binding. However, the catalytically in-
active BAP1(C91S) mutant bound with equal efficiency as
wild-type (WT) BAP1 to FOXK2 (Supplementary Figure
S3).
Together these results suggest that BAP1 has to be struc-
turally intact to bind to FOXK2 and that binding occurs
through the N-terminal FHA domain of FOXK2.
FOXK2 and the PR-DUB bind to the same genomic regions
Having established that FOXK2 and BAP1 interact in vivo,
we next established whether they could bind to the same
genomic regions. Previously we identified the FOXK2 ge-
nomic binding regions in U2OS cells by ChIP-seq (12). We
therefore tested four of these for endogenous BAP1 binding
(Figure 4A) and verified FOXK2 occupancy (Supplemen-
tary Figure S4) by qPCR-ChIP. Binding of both FOXK2
and BAP1 was detected at all of these regions while the con-
trol intronic region from the MCM3 locus exhibited bind-
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Figure 4. FOXK2 and the PR-DUB bind to the same chromatin regions. ChIP-qPCR analysis of endogenous BAP1 (A) and the other PR-DUB compo-
nents HCFC1 and ASXL2 (B) binding to the indicated FOXK2 genomic binding regions. Blacks bars in (B) represent binding to FOXK2 binding regions
associated with theMCM3 and KDM3A loci; white bars are negative control region which does not bind to FOXK2 (MCM3-int9). Data are normalized
against input DNA and shown relative to binding to non-specific IgG (taken as 1). Data are the average of three independent experiments. (C) Genome
wide correlation between FOXK2 and HCFC1 (23) binding regions. Heatmap of HCFC1 and FOXK2 read densities mapped onto FOXK2 peak summits
and ranked according to FOXK2 signal. (D) UCSC genome browser view of FOXK2 and HCFC1 binding profiles associated with the DDX19A and
VPS51 loci.
ing levels close to background binding observed with con-
trol IgG. Binding of Flag-tagged BAP1 was also detected at
several of these regions (Supplementary Figure S5A). Fur-
thermore, we could also detect binding of the other PR-
DUB complex member ASXL2 andHCFC1 at the FOXK2
binding regions associated with the MCM3 and KDM3A
loci (Figure 4B). We also compared the genome-wide bind-
ing profile for FOXK2 (12) with that of HCFC1 (23), and
found a strong co-association (Figure 4C), despite the dif-
ferent cell types being studied (U2OS versus HeLa). Indeed
60% (2203/3674) of the summits of the HCFC1 binding re-
gions are located within 200 nucleotides of a FOXK2 bind-
ing region summit as exemplified by the regions associated
with the DDX19A and VPS51 loci (Figure 4D). Similar
ChIPseq datasets are not available for BAP1, and our at-
tempts to generate such datasets using stable cell lines ex-
pressing Flag-tagged BAP1 yielded only a handful of bind-
ing regions, therefore we were unable to do a global com-
parison for BAP1.
Functional interactions between FOXK2 and BAP1 in target
locus regulation
To establish whether FOXK2 and BAP1 functionally inter-
act, we first compared two microarray studies performed
in U2OS cells where either FOXK2 (12) or BAP1 (22) had
been depleted by siRNA and shRNA treatment respectively
to identify commonly regulated genes. A large number of
genes were identified which were either commonly down-
regulated (249 genes) or up-regulated (371 genes) upon de-
pletion of either factor (Figure 5A). Importantly, these over-
laps were highly statistically significant whereas genes that
were reciprocally regulated upon BAP1 and FOXK2 de-
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pletion were far fewer in number and were either insignif-
icant or lowly significant compared to randomized datasets
(Figure 5B). This indicates a common mode of function
for FOXK2 and BAP1 in either up- or down-regulating
gene transcription. To focus on potential direct FOXK2 tar-
gets we associated the commonly deregulated genes with
FOXK2 binding events (within ±5 kb from the TSS) from
our ChIP-seq data, leaving 184 (74%) commonly down-
regulated and 263 (71%) commonly up-regulated genes. We
selected one gene from each class of co-regulated genes
for detailed verification and subsequent further analysis;
TP53I3 (up-regulated upon depletion) andH2AFX (down-
regulated upon depletion). Depletion of either FOXK2 or
BAP1 led to enhanced TP53I3 expression whereasH2AFX
expression was decreased as expected from the microarray
analysis (Figure 5C). We also tested combinatorial deple-
tion of FOXK2 and BAP1, and while increased activation
of TP53I3 was observed, no further reductions in H2AFX
occurred upon depletion of both FOXK2 and BAP1 (Sup-
plementary Figure S5).
Next, we verified FOXK2 and BAP1 occupancy in the
regulatory regions of these genes, and binding of both fac-
tors was detected (Figure 6A).UponFOXK2depletion (e.g.
Supplementary Figure S6B), both FOXK2 and BAP1 bind-
ing was diminished at both the TP53I3 and H2AFX loci,
indicating a role for FOXK2 in BAP1 recruitment (Figure
6A). To further extend this finding, we also tested two re-
gions that were identified by our ChIP-seq analysis of Flag-
tagged BAP1. We verified BAP1 binding and both regions
also exhibited FOXK2 occupancy. Importantly, FOXK2
depletion also caused reduced BAP1 binding to these loci,
further emphasizing its role in BAP1 recruitment (Figure
6A, bottom graphs). We also tested whether there was a re-
ciprocal effect on FOXK2 binding upon BAP1 depletion
but little effect was seen on the ChIP signal for FOXK2
following reductions in BAP1 expression levels by siRNA
treatment (Figure 6B; Supplementary Figure S6B).
BAP1 has been shown to be responsible for his-
tone H2AK119 deubiquitination (32), therefore we tested
whether BAP1 functioned in this manner at the regulatory
loci controlled by FOXK2 and BAP1. Depletion of BAP1
caused increases of histone ubiquitination at all of the reg-
ulatory loci, albeit often to moderate levels (Figure 6C).
Depletion of FOXK2 had less effect, but depletion of both
factors together caused a significant increase in H2AK119
ubiquitination at all loci tested (Figure 6C). Longer term
depletion of FOXK2 in stable FOXK2-depleted cell lines
led to bigger increases in H2AK119 ubiquitination at the
TP53I3 and H2AFX regulatory regions, consistent with its
role in BAP1 recruitment to these loci (Supplementary Fig-
ure S7).
Collectively, these results demonstrate that FOXK2 func-
tions together with BAP1 to control transcription in either
a positive or negative manner. In this context, FOXK2 acts
to recruit the PR-DUB complex component BAP1 to chro-
matin and thereby promote local histone deubiquitination.
DISCUSSION
Transcriptional control of gene expression is controlled in
part through localized changes in chromatin architecture.
This is driven by a wide array of different histone modi-
fications which themselves are generated under the direc-
tion of sequence-specific transcription factors and are of-
ten dynamically modified in response to changes in the cel-
lular environment (reviewed in (33)). Here, we have stud-
ied the forkhead transcription factor FOXK2 and demon-
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Figure 6. FOXK2 acts as a chromatin targeting factor for the BAP1-containing deubiquitinase complex. ChIP analysis of endogenous FOXK2 and BAP1
binding to the indicated genomic loci in U2OS cells treated with non-targeting control siRNAs (siNT, black bars) or siRNA against FOXK2 (siFOXK2,
white bars) (A) or siRNA against BAP1 (siBAP1, grey bars) (B). ChIP was performed with nonspecific IgG or anti-FOXK2 and BAP1 antibodies; the
data are shown relative to the input DNA and are the averages of two (B) or three (A) experiments. (C) ChIP analysis of H2A and H2AK119 ubiquitin
levels at the indicated genomic loci in U2OS cells treated with non-targetting control siRNAs (siNT; light grey bars), siRNA against BAP1 (siBAP1; dark
grey bars), siRNA against FOXK2 (siFOXK2; white bars) or both BAP1 and FOXK2 (black bars). ChIP was performed with non-specific IgG, anti-H2A
and ubiquitinated K119 H2A antibodies (H2Aub); the data are the averages of three experiments. Statistically significant differences between siNT and
siBAP1/siFOXK2 treated samples are shown; P-value <0.05 (*) and <0.01(**). (D) Model depicting the role of FOXK2 in nucleating the recruitment
of chromatin remodelling complexes to chromatin. FOXK2 recruits both the PR-DUB and the SIN3A complex, potentially through direct or indirect
interactions with the shared subunit HCFC1. Question marks denote uncertainty about which interactions are direct. BAP1 can then cause local histone
deubiquitination, and histone deacetylation can potentially be achieved through the HDAC1 component of the SIN3A complex.
strate that it can recruit the PR-DUB complex to chro-
matin, where it canmodify the local chromatin environment
by promoting histone deubiquitination through its BAP1
subunit (see model in Figure 6D). While we have provided
most evidence to support this element of our model, we also
demonstrate that FOXK2 can also bind to the SIN3A co-
repressor complex, potentially allowing localized histone
deacetylation as well as deubiquitination.
BAP1 is becoming increasingly recognized as an impor-
tant protein in the context of tumourigenesis. BAP1 is often
mutated or deleted in a range of cancers, most commonly
in uveal melanomas, malignant pleural mesotheliomas and
clear cell renal carcinomas (reviewed in (29,30)) indicating
that it represents a tumour suppressor protein. Recently,
its importance was further emphasized as an extensive can-
cer sequencing study found BAP1 to be one of seven genes
whose mutation is the most indicative of poor prognostic
outcome (30). Previous studies have suggested that HCFC1
binds to BAP1 and can therefore potentially recruit it to
chromatin (28,34). As HCFC1 can also bind to E2F tran-
scription factors, this provides a potential route to specific
recruitment of BAP1 to regulatory regions in chromatin
(35). Indeed, BAP1 depletion leads to changes in E2F tar-
get gene expression, although a role for E2F in nucleating
this event was not demonstrated (36). More recently, YY1
was shown to permit recruitment of BAP1 to the regulatory
region of the COX7C gene to activate its expression (22).
Here, we provide an alternative route through which BAP1
can be recruited to specific genomic regions through the
transcription factor FOXK2. As FOXK2 occupies thou-
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sands of genomic loci, many of which are found in open
chromatin (12), this provides a molecular mechanism to
help explain how BAP1 might function across the genome.
In addition to binding to the PR-DUB complex, we also
found that FOXK2 can bind to the SIN3A co-repressor
complex, with interactions detected with SIN3A, RBBP4,
RBBP7 and HDAC1. This is in keeping with the obser-
vation that the closely related FOXK1 can also bind to
the SIN3 complex (7,8), and suggests a repressive role for
FOXK2 in this context. One way in which FOXK2 might
repress transcription is through the HDAC1 subunit of this
complex, which would lead to localized histone deacetyla-
tion and hence changes in chromatin structure. It is possible
that this activity might synergize with the effects of histone
deubiquitination through the PR-DUB complex, but it is
unclear whether FOXK2 recruits these to the same regula-
tory loci either at the same time or in a sequential manner.
However, it is intriguing that the FOXK2 interacting pro-
teinHCFC1 has previously been shown to also bind to both
SIN3A and BAP1 (Figure 1C; (28,34,37)), thereby provid-
ing a potential platform for recruiting both complexes to
FOXK2 (see model in Figure 6D). However, it is unclear
whether FOXK2 makes direct interactions with HCFC1,
BAP1, subunits of the SIN3A complex or combinations of
these.
Histone H2AK119 ubiquitination is typically thought of
as repressive in nature (38), and thus the recruitment of
the BAP1 deubiquitinating enzyme would be expected to
promote transcriptional activation. However, the PR-DUB
complex is not generally associated with transcriptional ac-
tivation mechanisms and instead appears to be repressive
in nature, potentially through promoting histone ubiquiti-
nation dynamics (reviewed in (39)). Indeed, this is consis-
tent with our demonstration that BAP1 depletion causes
increased ubiquitination levels at regulatory regions associ-
ated with genes that are either repressed or activated under
the same conditions (see Figures 5C and 6C). It remains un-
clear though whether the changes in histone ubiquitination
we observe have a direct influence on the outcome of tran-
scription at associated target gene loci. For example, tran-
sient depletion of FOXK2 has little effects on steady state
histone ubiquitination levels (Figure 6C) and yet influences
both TP53I3 and H2AFX transcription (Figure 5C). Fur-
thermore, FOXK2 and BAP1 depletion synergizes to cause
enhanced TP53I3 gene activation (Supplementary Figure
S5), but no synergy is seen at the H2A ubiquitination level
(Figure 6C). Thus, although it is clear that FOXK2 recruits
BAP1 and influences histone ubiquitination levels, there is
no clear link between the chromatin changes and gene reg-
ulation. These observations point to additional important
regulatory activities of FOXK2 and/or BAP1 which may
function in a locus-specific manner. Moreover, it is possible
that FOXK2 might coordinate the recruitment of repres-
sive and activating complexes to the same loci to turn the
regulatory regions on or off under different conditions. Al-
ternatively, FOXK2 might be repressive in nature at some
loci but activating at others. Indeed, in keeping with this
hypothesis, we previously demonstrated that roughly equiv-
alent numbers of direct FOXK2 target genes were up- and
down-regulated following FOXK2 depletion (12).
Our demonstration that FOXK2 can function in modify-
ing chromatin structure through recruiting histone deacety-
lation and deubiquitination complexes, adds to a growing
number of connections with chromatin-associated events.
For example, one recent study identified FOXK2 as a com-
ponent of 5-hydroxymethylcytosine–DNA binding protein
complexes (40) whereas another studied indicated that
FOXK2 showed a preference for binding 5-formylcytosine
(41), suggesting that there is a relationship between FOXK2
and regions containing either methylated DNA or its
derivatives. More recently, we have shown that FOXK2 and
BAP1 are also components of complexes containing the
MBD5/6 methyl binding domain family members (42). It
will be interesting to determine whether FOXK2-mediated
recruitment of the PR-DUB complex has functionally im-
portant interactions with other chromatin components that
recognize the underlying methylation state of the genome.
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